Catalyst Wire Dossier Catalyst Wire Dossier

GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR

GLUCAGON INJECTION, SOLUTION · Xeris Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR, covering 2019-09-10 to 2025-03-14. Get the full timeline:

Most recent: FDA Approved: GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR — Supplemental Application (Xeris Pharmaceuticals, Inc.)

See pricing